17/05/2026
This AACE 2026 diabetes algorithm actually reflects something many of us in integrative and metabolic medicine have been seeing clinically for years: diabetes is no longer being viewed as “just a glucose disease,” but as a systemic metabolic disorder involving obesity, cardiovascular risk, fatty liver, sleep apnea, inflammation, and endocrine dysfunction. 
What stands out to me most is the shift from a purely glucose-centric model toward a complications- and comorbidities-centric framework.  In other words, modern diabetes care is increasingly focusing on the entire metabolic ecosystem, not just HbA1c numbers. That direction is highly relevant to how many of us in TCM approach chronic metabolic disease — pattern recognition, systemic regulation, sleep, stress, digestion, inflammation, weight, and long-term functional resilience.
Another important evolution is the recognition that obesity management is now considered a “key pillar” rather than a secondary issue.  This is a major conceptual shift. In many endocrine and fertility-related conditions — including PCOS, insulin resistance, MASLD, and metabolic syndrome — metabolic regulation is increasingly becoming the core therapeutic target.
Interestingly, the document also repeatedly emphasizes lifestyle, sleep, behavioral health, and individualized care.  That tells us modern medicine itself is moving toward a more systems-oriented direction.
The future of diabetes management may not be “Western medicine vs TCM.”
It may be about building a clinically measurable, evidence-based metabolic medicine model that integrates the strengths of both.
